TRIM63 and cancer: Downregulated pathways in survivors at these timepoints included those involved in innate immunity signaling (“role of pattern recognition receptors in recognition of bacteria and viruses”, “interferon signaling”, “activation of IRF by cytosolic pattern recognition receptors”) or immune dysregulation (“systemic lupus erythematous in B cell signaling pathway”, “PD-1, PDL-1 cancer immunotherapy”).